Evaluating the Efficacy of Coronavirus Disease 2019 Vaccines

A large number of studies are being conducted to evaluate the efficacy and safety of candidate vaccines against coronavirus disease 2019 (COVID-19). Most phase 3 trials have adopted virologically confirmed symptomatic COVID-19 as the primary efficacy end point, although laboratory-confirmed severe a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Zeng, Donglin, Mehrotra, Devan V, Corey, Lawrence, Gilbert, Peter B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Invited Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799296/
https://www.ncbi.nlm.nih.gov/pubmed/33340397
http://dx.doi.org/10.1093/cid/ciaa1863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799296/
https://www.ncbi.nlm.nih.gov/pubmed/33340397
http://dx.doi.org/10.1093/cid/ciaa1863

Ejemplares similares